ATORVASTATIN CALCIUM
- Product NDC
- 70934-360
- 11-digit product format
- 709340360
- Labeler code
- 70934
- Product ID
- 70934-360_f15e5445-c867-c0d1-e053-2995a90a4848
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA207687
- Marketing category
- ANDA
- Marketing start
- 2019-05-06
- Marketing end
- 2023-05-31
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-360-30 | 70934036030 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-360-30) | 2019-05-06 | 0000-00-00 | No | No | Current |